Search

Your search keyword '"McCarthy, Lisa"' showing total 580 results
Start Over Author "McCarthy, Lisa"
580 results on '"McCarthy, Lisa"'

2. Preventing Prescribing Cascades: Ensuring Medication Safety for Older Adults

Author

Wahler, Robert G., Jr., Olbrich, Courtney L., and McCarthy, Lisa M.

Subjects
Medication errors -- Prevention, Aged patients -- Care and treatment, Prescription writing -- Evaluation
Abstract

Purpose: To define prescribing cascades (PCs) and provide tools to identify PCs, including the most common PCs described in the literature. PCs lead to the accumulation of medications prescribed to older adults, disproportionately affecting those who often have additional health care complexities, such as multiple chronic conditions and multiple transitions of care. Method: Review of recent research efforts to identify and describe evolving clinical practice interventions to detect and reverse PCs. Results: Clinicians can contribute to mitigating PCs through better understanding of how PCs occur in practice. Armed with this knowledge, clinical team members can implement proposed strategies and techniques to engage in primary and secondary prevention of PCs. Conclusion: Ultimately, PCs are a culprit of preventable medication harm. Several tools are presented, which are initiated through maintaining a high index of suspicion for PCs in the evaluation of a new symptom presentation by older patients. [Journal of Gerontological Nursing, 50(9), 7–11.], One in five adult patients experience a hospital-related medication error in the form of an adverse drug reaction (ADR) (Alqenae et al., 2020). Traumatically, some ADRs cost patients their lives. [...]

Published
2024
Full Text
View/download PDF

7. Deprescription de la medication contre le diabete chez les personnes agees fragiles

Author

Lega, Iliana C., Thompson, Wade, and McCarthy, Lisa M.

Subjects
Frail elderly -- Health aspects -- Drug therapy, Diabetes -- Drug therapy -- Physiological aspects, Drug therapy -- Physiological aspects -- Complications and side effects, Health
Abstract

1 Une therapie agressive contre le diabete de type 2 est nefaste pour les personnes agees fragiles Traiter les personnes atteintes par une regulation intensive de la glycemie (hemoglobine glyquee [...]

Published
2024
Full Text
View/download PDF

20. Deprescribing: Future directions for research

Author

Thompson, Wade, Reeve, Emily, Moriarty, Frank, Maclure, Malcolm, Turner, Justin, Steinman, Michael A, Conklin, James, Dolovich, Lisa, McCarthy, Lisa, and Farrell, Barbara

Subjects
Health Services and Systems, Health Sciences, Comparative Effectiveness Research, Good Health and Well Being, Clinical Trials as Topic, Deprescriptions, Humans, Patient Participation, Practice Guidelines as Topic, Research, Deprescribing, Guidelines, Polypharmacy, Pharmacology and Pharmaceutical Sciences, Public Health and Health Services, Pharmacology & Pharmacy, Health services and systems, Public health
Abstract

A World Café workshop was held at the Bruyère Evidence-Based Deprescribing Guidelines Symposium in March 2018 with 30 participants (researchers, clinicians, policy makers, stakeholders). This workshop explored priorities for future work in the field of deprescribing and deprescribing guidelines through group discussion. The discussions were guided by the following questions: (1) What are deprescribing research priorities (to inform guideline development), (2) What outcome measures are important for developing deprescribing guidelines, and (3) How do we evaluate the implementation and effectiveness of deprescribing guidelines? Discussion from all 3 questions identified 6 main priority areas: (1) conducting high-quality and long-term clinical trials that measure patient-important outcomes, (2) focusing on patient involvement and perspectives, (3) investigating the pharmacoeconomics of deprescribing interventions, (4) understanding deprescribing interventions in different populations, (5) generating evidence on clinical management during deprescribing (e.g. managing adverse drug withdrawal effects, subsequent re-prescribing), and (6) implementing interventions in clinical practice. These topics represent what a group of experienced researchers, clinicians, and stakeholders in the field collectively felt was important to consider for design and implementation of future deprescribing studies. The aim is for these findings to stimulate future discussions and be considered by granting agencies, policy makers, deprescribing research networks, and individual researchers planning future deprescribing studies.

Published
2019

29. Creating a patient reported outcome measure for medication-related quality of life: a concept mapping brainstorming study in Ontario, Canada

Author

Guilcher, Sara, primary, Zidarov, Diana, additional, Everall, Amanda, additional, Cadel, Lauren, additional, Cimino, Stephanie, additional, Kaiser, Anita, additional, MacKay, Crystal, additional, McCarthy, Lisa, additional, O'Connell, Colleen, additional, Milligan, James, additional, Lofters, Aisha, additional, and Hitzig, Sander, additional

Published
2023
Full Text
View/download PDF

30. Association of a calcium channel blocker and diuretic prescribing cascade with adverse events: A population‐based cohort study

Author

Rochon, Paula A., primary, Austin, Peter C., additional, Normand, Sharon‐Lise, additional, Savage, Rachel D., additional, Read, Stephanie H., additional, McCarthy, Lisa M., additional, Giannakeas, Vasily, additional, Wu, Wei, additional, Strauss, Rachel, additional, Wang, Xuesong, additional, Chen, Simon, additional, and Gurwitz, Jerry H., additional

Published
2023
Full Text
View/download PDF

35. The prevalence and regional variability of diabetes among nursing home residents in Ontario.

Author

Farahvash, Armin, McCarthy, Lisa M., Thompson, Wade, Podolsky, Sho, and Lega, Iliana C.

Subjects
*DIABETES risk factors, *LENGTH of stay in hospitals, *OBESITY, *RESEARCH methodology, *ONE-way analysis of variance, *AGE distribution, *DIABETES, *POPULATION geography, *RISK assessment, *DISEASE prevalence, *CHI-squared test, *DESCRIPTIVE statistics, *RESEARCH funding, *QUESTIONNAIRES, *BODY mass index, *LONGITUDINAL method, *COMORBIDITY
Published
2024
Full Text
View/download PDF

36. Association of a calcium channel blocker and diuretic prescribing cascade with adverse events: A population‐based cohort study.

Author

Rochon, Paula A., Austin, Peter C., Normand, Sharon‐Lise, Savage, Rachel D., Read, Stephanie H., McCarthy, Lisa M., Giannakeas, Vasily, Wu, Wei, Strauss, Rachel, Wang, Xuesong, Chen, Simon, and Gurwitz, Jerry H.

Subjects
DIURETICS, HYPERTENSION, CONFIDENCE intervals, CALCIUM antagonists, REGRESSION analysis, COMPARATIVE studies, DRUG prescribing, RESEARCH funding, INDEPENDENT living, HOSPITAL care, PHYSICIAN practice patterns, LONGITUDINAL method, EMERGENCY room visits
Abstract

Background: Prescribing cascades occur when a drug adverse event is misinterpreted as a new medical condition and a second, potentially unnecessary drug, is prescribed to treat the adverse event. The population‐level consequences of prescribing cascades remain unknown. Methods: This population‐based cohort study used linked health administrative databases in Ontario, Canada. The study included community‐dwelling adults, 66 years of age or older with hypertension and no history of heart failure (HF) or diuretic use in the prior year, newly dispensed a calcium channel blocker (CCB). Individuals subsequently dispensed a diuretic within 90 days of incident CCB dispensing were classified as the prescribing cascade group, and compared to those not dispensed a diuretic, classified as the non‐prescribing cascade group. Those with and without a prescribing cascade were matched one‐to‐one on the propensity score and sex. The primary outcome was a serious adverse event (SAE), which was the composite of emergency room visits and hospitalizations in the 90‐day follow‐up period. We estimated hazard ratios (HRs) with 95% confidence intervals (CI) for SAE using an Andersen–Gill recurrent events regression model. Results: Among 39,347 older adults with hypertension and no history of HF who were newly dispensed a CCB, 1881 (4.8%) had a new diuretic dispensed within 90 days after CCB initiation. Compared to the non‐prescribing cascade group, those in the prescribing cascade group had higher rates of SAEs (HR: 1.21, 95% CI: 1.02–1.43). Conclusions: The CCB‐diuretic prescribing cascade was associated with an increased rate of SAEs, suggesting harm beyond prescribing a second drug therapy. Our study raises awareness of the downstream impact of the CCB‐diuretic prescribing cascade at a population level and provides an opportunity for clinicians who identify this prescribing cascade to review their patients' medications to determine if they can be optimized. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

38. Student Competition (Knowledge Generation) ID 1985014

Author

Cadel, Lauren, primary, Hitzig, Sander L, additional, McCarthy, Lisa M, additional, Hahn-Goldberg, Shoshana, additional, Packer, Tanya L, additional, Ho, Chester H, additional, Lofters, Aisha K, additional, Patel, Tejal, additional, Cimino, Stephanie R, additional, and Guilcher, Sara JT, additional

Published
2023
Full Text
View/download PDF

40. Exploring physician gender bias in the initiation of prescribing cascades for older men and women: a qualitative clinical vignette study protocol

Author

Borhani, Parya, primary, Rochon, Paula A, additional, Carrieri, Barbara, additional, Dalton, Kieran, additional, Lawson, Andrea, additional, Li, Joyce, additional, Mason, Robin, additional, McCarthy, Lisa M, additional, Paoletti, Luca, additional, Santini, Sara, additional, Sivayoganathan, Kawsika, additional, Sternberg, Shelley, additional, Zwas, Donna R, additional, and Savage, Rachel D, additional

Published
2023
Full Text
View/download PDF

46. A scoping review of medication self-management intervention tools to support persons with traumatic spinal cord injury

Author

Cadel, Lauren, primary, Cimino, Stephanie R., additional, Bradley-Ridout, Glyneva, additional, Hitzig, Sander L., additional, Packer, Tanya L., additional, McCarthy, Lisa M., additional, Patel, Tejal, additional, Lofters, Aisha K., additional, Hahn-Goldberg, Shoshana, additional, Ho, Chester H., additional, and Guilcher, Sara J. T., additional

Published
2023
Full Text
View/download PDF

47. Rates of overtreatment and deprescribing of antihyperglycemics among long‐term care residents in British Columbia

Author

Pan, Jeffrey, primary, Tejani, Aaron, additional, Logan, Alixandra, additional, Brodoway, Heather, additional, Shukla, Kruti, additional, Son, Maric, additional, Khosla, Kanika, additional, Moradi, AmirHossein, additional, Drummond, Isla, additional, McCarthy, Lisa M., additional, Lega, Iliana C., additional, McCracken, Rita, additional, and Thompson, Wade, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results